FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Clegg

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jessica A Walsh; Gerald G Krueger; Kristina Callis Duffin; Daniel O Clegg
Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.
Jessica A Walsh; Julia Crim; Kristina Callis Duffin; Daniel O Clegg
Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.
Man Hung; Florian Nickisch; Timothy C Beals; Daniel O Clegg; Tom Greene; Charles L Saltzman
New paradigm for patient-reported outcomes assessment in foot & ankle research: computerized adaptive testing.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Clegg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jessica A Walsh; Gerald G Krueger; Kristina Callis Duffin; Daniel O Clegg
Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.
The Journal of rheumatology 2013;40(3):287-93.
2012: Jessica A Walsh; Julia Crim; Kristina Callis Duffin; Daniel O Clegg
Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2012;8(6):643-8.
2012: Man Hung; Florian Nickisch; Timothy C Beals; Daniel O Clegg; Tom Greene; Charles L Saltzman
New paradigm for patient-reported outcomes assessment in foot & ankle research: computerized adaptive testing.
Foot & ankle international. / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society 2012;33(8):621-6.
2012: Atul Deodhar; Daniel O Clegg
Management of ankylosing spondylitis: what is known; what is not known?
The American journal of the medical sciences 2012;343(5):343-4.
2012: Gary A Kunkel; Grant W Cannon; Daniel O Clegg
Combined structural and synovial assessment for improved ultrasound discrimination of rheumatoid, osteoarthritic, and normal joints: a pilot study.
The open rheumatology journal 2012;6():199-206.
2011: Man Hung; Daniel O Clegg; Tom Greene; Charles L Saltzman
Evaluation of the PROMIS physical function item bank in orthopaedic patients.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2011;29(6):947-53.
2011: Luis R Espinoza; John D Reveille; Daniel O Clegg
Prologue: 2010 Spondyloarthritis Research and Therapy Network (SPARTAN) annual research and education meeting.
The American journal of the medical sciences 2011;341(4):266-8.
2011: Karla L Miller; Daniel O Clegg
Glucosamine and chondroitin sulfate.
Rheumatic diseases clinics of North America 2011;37(1):103-18.
2010: John D Reveille; Daniel O Clegg
Prologue: 2009 Joint Meeting of Spondyloarthritis Research and Therapy Network (SPARTAN) and International Genetics of Ankylosing Spondylitis (IGAS).
The Journal of rheumatology 2010;37(12):2604-5.
2010: Allen D Sawitzke; Helen Shi; Martha F Finco; Dorothy D Dunlop; Crystal Harris; Nora G Singer; John D Bradley; David Silver; Christopher G Jackson; Nancy E Lane; Chester V Oddis; Fred Wolfe; Jeffrey Lisse; Daniel E Furst; Clifton O Bingham; Domenic Reda; Roland W Moskowitz; H James Williams; Daniel O Clegg
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.
Annals of the rheumatic diseases 2010;69(8):1459-64.
2008: Allen D Sawitzke; Helen Shi; Martha F Finco; Dorothy D Dunlop; Clifton O Bingham; Crystal Harris; Nora G Singer; John D Bradley; David Silver; Christopher G Jackson; Nancy E Lane; Chester V Oddis; Frederick Wolfe; Jeffrey Lisse; Daniel E Furst; Domenic Reda; Roland W Moskowitz; H James Williams; Daniel O Clegg
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.
Arthritis and rheumatism 2008;58(10):3183-91.
2008: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; Daniel O Clegg; Alan J Kivitz; R M Fleischmann; Robert D Inman; L Ni; S-L Lin; Wayne Tsuji
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2008;67(3):346-52.
2007: Tracy M Frech; Daniel O Clegg
The utility of nutraceuticals in the treatment of osteoarthritis.
Current rheumatology reports 2007;9(1):25-30.
2006: Daniel O Clegg
Treatment of ankylosing spondylitis.
The Journal of rheumatology. Supplement 2006;78():24-31.
2006: Daniel O Clegg; Domenic Reda; Crystal Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
The New England journal of medicine 2006;354(8):795-808.
2006: Jamie G Barnhill; Carol L Fye; David W Williams; Domenic Reda; Crystal Harris; Daniel O Clegg
Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial.
Journal of the American Pharmacists Association : JAPhA 2006;46(1):14-24.
2005: John C Davis; Désirée van der Heijde; Maxime Dougados; Jurgen Braun; John J Cush; Daniel O Clegg; Robert D Inman; Todd de Vries; Wayne Tsuji
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
The Journal of rheumatology 2005;32(9):1751-4.
2003: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; John J Cush; Daniel O Clegg; Alan J Kivitz; Roy Fleischmann; Robert Inman; Wayne Tsuji
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis and rheumatism 2003;48(11):3230-6.
1999: Daniel O Clegg; Domenic Reda; Mazen Abdellatif
Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
Arthritis and rheumatism 1999;42(11):2325-9.
1999: Barbara C Tilley; Stanley R Pillemer; SP Heyse; S Li; Daniel O Clegg; GS Alarcón
Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.
Arthritis and rheumatism 1999;42(9):1879-88.
1999: M R Cohen; Domenic Reda; Daniel O Clegg
Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies.
The Journal of rheumatology 1999;26(8):1752-6.
1999: Michael J Battistone; BJ Manaster; Domenic Reda; Daniel O Clegg
The prevalence of sacroilitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study.
Skeletal radiology 1999;28(4):196-201.
1999: H James Williams; G S Alarcon; R Joks; Virginia Steen; K Bulpitt; Daniel O Clegg; CAROL ZIMINSKI; M E Luggen; E William St Clair; RF Willkens; C Yarboro; JG Morgan; MJ Egger; J R Ward
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
The Journal of rheumatology 1999;26(4):816-25.
1999: S Silas; Daniel O Clegg
Selective COX-2 inhibition.
Bulletin on the rheumatic diseases 1999;48(2):1-4.
1998: Michael J Battistone; BJ Manaster; Domenic Reda; Daniel O Clegg
Radiographic diagnosis of sacroiliitis--are sacroiliac views really better?
The Journal of rheumatology 1998;25(12):2395-401.
1998: H James Williams; GS Alarcón; R Neuner; Virginia Steen; K Bulpitt; Daniel O Clegg; CAROL ZIMINSKI; M E Luggen; Richard Polisson; RF Willkens; C Yarboro; J Morgan; MJ Egger; J R Ward
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
The Journal of rheumatology 1998;25(2):261-8.
1998: M L Barnett; Joel M Kremer; E William St Clair; Daniel O Clegg; Daniel E Furst; Michael Weisman; M J Fletcher; S Chasan-Taber; E Finger; A Morales; CH Le; DE Trentham
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
Arthritis and rheumatism 1998;41(2):290-7.
1997: M Tuttleman; Stanley R Pillemer; Barbara C Tilley; SE Fowler; L M Buckley; GS Alarcón; DE Trentham; R Neuner; Daniel O Clegg; JC Leisen; SP Heyse
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
The Journal of rheumatology 1997;24(10):1910-5.
1997: Daniel O Clegg; Fredrick Dietz; J Duffy; RF Willkens; Eric Hurd; B F Germain; B Wall; D J Wallace; C L Bell; J Sleckman
Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine.
The Journal of rheumatology 1997;24(10):1896-902.
1997: G B Bluhm; J T Sharp; Barbara C Tilley; G S Alarcon; S M Cooper; Stanley R Pillemer; Daniel O Clegg; SP Heyse; DE Trentham; R Neuner; D A Kaplan; JC Leisen; L Buckley; H Duncan; M Tuttleman; S Li; SE Fowler
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
The Journal of rheumatology 1997;24(7):1295-302.
1997: Stanley R Pillemer; SE Fowler; Barbara C Tilley; GS Alarcón; SP Heyse; DE Trentham; R Neuner; Daniel O Clegg; JC Leisen; S M Cooper; H Duncan; M Tuttleman
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
Arthritis and rheumatism 1997;40(3):419-25.
1996: G S Alarcón; Barbara C Tilley; S Cooper; Daniel O Clegg; DE Trentham; Stanley R Pillemer; R Neuner; S Fowler
Another look at minocycline.
Bulletin on the rheumatic diseases 1996;45(8):6-7.
1996: Daniel O Clegg; Domenic Reda; M H Weisman; J J Cush; Frank B Vasey; H R Schumacher; E Budiman-Mak; D J Balestra; W D Blackburn; Grant W Cannon; R D Inman; F P Alepa; E Mejias; M R Cohen; R Makkena; M L Mahowald; J Higashida; S L Silverman; N Parhami; J Buxbaum; C M Haakenson; R H Ward; BJ Manaster; R J Anderson; W G Henderson
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.
Arthritis and rheumatism 1996;39(12):2021-7.
1996: Daniel O Clegg; Domenic Reda; E Mejias; Grant W Cannon; M H Weisman; T Taylor; E Budiman-Mak; W D Blackburn; Frank B Vasey; M L Mahowald; J J Cush; H R Schumacher; S L Silverman; F P Alepa; M E Luggen; M R Cohen; R Makkena; C M Haakenson; R H Ward; BJ Manaster; R J Anderson; J R Ward; W G Henderson
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.
Arthritis and rheumatism 1996;39(12):2013-20.
1996: Daniel O Clegg; Domenic Reda; M H Weisman; W D Blackburn; J J Cush; Grant W Cannon; M L Mahowald; H R Schumacher; T Taylor; E Budiman-Mak; M R Cohen; Frank B Vasey; M E Luggen; E Mejias; S L Silverman; R Makkena; F P Alepa; J Buxbaum; C M Haakenson; R H Ward; BJ Manaster; R J Anderson; J R Ward; W G Henderson
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
Arthritis and rheumatism 1996;39(12):2004-12.
1996: J D Reveille; G S Alarcón; SE Fowler; Stanley R Pillemer; R Neuner; Daniel O Clegg; I S Mikhail; DE Trentham; J C Leisen; G Bluhm; S M Cooper; H Duncan; M Tuttleman; SP Heyse; J T Sharp; Barbara C Tilley
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
Arthritis and rheumatism 1996;39(11):1802-7.
1996: G S Alarcón; R F Willkens; J R Ward; Daniel O Clegg; J G Morgan; K N Ma; J Z Singer; Virginia D Steen; H E Paulus; M E Luggen; R P Polisson; CAROL ZIMINSKI; C Yarboro; H James Williams
Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline.
Arthritis and rheumatism 1996;39(3):403-14.
1995: Barbara C Tilley; G S Alarcón; SP Heyse; DE Trentham; R Neuner; D A Kaplan; Daniel O Clegg; J C Leisen; L Buckley; S M Cooper; H Duncan; Stanley R Pillemer; M Tuttleman; SE Fowler
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Annals of internal medicine 1995;122(2):81-9.
1994: H James Williams; MJ Egger; J Z Singer; R F Willkens; K C Kalunian; Daniel O Clegg; J L Skosey; R H Brooks; G S Alarcón; Virginia D Steen
Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus.
The Journal of rheumatology 1994;21(8):1457-62.
1994: Daniel O Clegg; James C Reading; MD Mayes; James R Seibold; C Harris; Fredrick M Wigley; J R Ward; E J Pisko; M H Weisman; P Lee
Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
The Journal of rheumatology 1994;21(1):105-10.
1993: D J Bjorkman; M Boschert; K G Tolman; Daniel O Clegg; J R Ward
The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
Arthritis and rheumatism 1993;36(12):1697-701.
1993: H James Williams; J R Ward; MJ Egger; R Neuner; R H Brooks; Daniel O Clegg; Elizabeth H Field; J L Skosey; G S Alarcón; R F Willkens
Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee.
Arthritis and rheumatism 1993;36(9):1196-206.
1993: Ken J Bulpitt; P J Clements; P A Lachenbruch; H E Paulus; J B Peter; M S Agopian; J Z Singer; Virginia D Steen; Daniel O Clegg; CAROL ZIMINSKI; G S Alarcon; M E Luggen; R P Polisson; R F Willkens; James C Reading; H James Williams; J R Ward
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).
Annals of internal medicine 1993;118(8):602-9.
1992: H James Williams; J R Ward; James C Reading; R H Brooks; Daniel O Clegg; J L Skosey; M H Weisman; R F Willkens; J Z Singer; G S Alarcón
Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.
Arthritis and rheumatism 1992;35(3):259-69.
1991: Daniel O Clegg; H James Williams; J Z Singer; Virginia D Steen; S Schlegel; CAROL ZIMINSKI; G S Alarcón; M E Luggen; R P Polisson; R F Willkens
Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
The Journal of rheumatology 1991;18(9):1340-3.
1991: G S Alarcón; G V Williams; J Z Singer; Virginia D Steen; Daniel O Clegg; H E Paulus; LYNN BILLINGSLEY; M E Luggen; R P Polisson; R F Willkens
Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease.
The Journal of rheumatology 1991;18(9):1332-9.
1989: Daniel O Clegg; D E Furst; K G Tolman; R Pogue
Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.
The Journal of rheumatology 1989;16(8):1123-6.
1989: C S Fehlauer; C W Carson; Grant W Cannon; J R Ward; C O Samuelson; H James Williams; Daniel O Clegg
Methotrexate therapy in rheumatoid arthritis: 2-year retrospective followup study.
The Journal of rheumatology 1989;16(3):307-12.
1988: D J Bjorkman; E H Hammond; R G Lee; Daniel O Clegg; K G Tolman
Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis.
Arthritis and rheumatism 1988;31(12):1465-72.
1988: H James Williams; J R Ward; S L Dahl; Daniel O Clegg; R F Willkens; T Oglesby; M H Weisman; S Schlegel; R M Michaels; M E Luggen
A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
Arthritis and rheumatism 1988;31(6):702-13.
1988: H James Williams; S L Dahl; J R Ward; M Karg; R F Willkens; R F Meenan; M Altz-Smith; Daniel O Clegg; W M Mikkelsen; D R Kay
One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
Arthritis and rheumatism 1988;31(1):9-14.
1987: G S Alarcón; LYNN BILLINGSLEY; Daniel O Clegg; J G Hardin; JOHN KLIPPEL; M E Luggen; R P Polisson; J Z Singer; L Szydlo; R F Willkens
Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid arthritis.
Arthritis and rheumatism 1987;30(2):218-20.
1985: G W Cannon; C G Jackson; C O Samuelson; J R Ward; H James Williams; Daniel O Clegg
Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review.
Seminars in arthritis and rheumatism 1985;15(2):106-18.
1984: C O Samuelson; M M Griffiths; J L Mathews; Daniel O Clegg; J R Ward
Susceptibility and resistance to 6-sulfanilamidoindazole-induced arthritis among inbred strains of rats.
Arthritis and rheumatism 1984;27(6):689-93.
1983: Grant W Cannon; J R Ward; Daniel O Clegg; C O Samuelson; T M Abbott
Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.
Arthritis and rheumatism 1983;26(10):1269-74.
1980: Daniel O Clegg; C O Samuelson; H James Williams; J R Ward
Articular complications of jejunoileal bypass surgery.
The Journal of rheumatology 1980;7(1):65-70.